VIRX

Viracta Therapeutics, Inc. Common Stock

Delisted

VIRX was delisted on the 3rd of February, 2025.

41 hedge funds and large institutions have $14.1M invested in Viracta Therapeutics, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 11 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more funds holding in top 10

Funds holding in top 10:

less funds holding

Funds holding:

less capital invested

Capital invested by funds: $ → $

36% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 11

64% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 11

Holders
41
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$9K
Puts
$3K
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
26
$17.9K
27
$17.5K
28
$14.4K
29
$10.6K
30
$7.11K
31
$6.12K
32
$5.22K
33
$4.23K
34
$4K
35
$1.02K
36
$484
37
$141
38
$12
39
$11
40
$6
41
42
43
44
45
46
47
48
49
50